A detailed history of Iowa State Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, Iowa State Bank holds 50,770 shares of ABBV stock, worth $8.32 Million. This represents 2.06% of its overall portfolio holdings.

Number of Shares
50,770
Previous 51,957 2.28%
Holding current value
$8.32 Million
Previous $8.05 Million 14.83%
% of portfolio
2.06%
Previous 1.94%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$159.82 - $182.1 $189,706 - $216,152
-1,187 Reduced 2.28%
50,770 $9.25 Million
Q4 2023

Jan 23, 2024

SELL
$137.6 - $154.97 $916,140 - $1.03 Million
-6,658 Reduced 11.36%
51,957 $8.05 Million
Q3 2023

Oct 24, 2023

BUY
$133.59 - $154.65 $110,612 - $128,050
828 Added 1.43%
58,615 $8.74 Million
Q2 2023

Aug 04, 2023

SELL
$132.51 - $164.9 $189,356 - $235,642
-1,429 Reduced 2.41%
57,787 $7.79 Million
Q1 2023

Apr 25, 2023

SELL
$144.61 - $166.54 $660,289 - $760,421
-4,566 Reduced 7.16%
59,216 $9.44 Million
Q4 2022

Jan 06, 2023

BUY
$138.31 - $165.87 $288,929 - $346,502
2,089 Added 3.39%
63,782 $10.3 Million
Q3 2022

Oct 14, 2022

SELL
$134.21 - $153.93 $294,456 - $337,722
-2,194 Reduced 3.43%
61,693 $8.28 Million
Q2 2022

Aug 05, 2022

SELL
$137.62 - $174.96 $181,796 - $231,122
-1,321 Reduced 2.03%
63,887 $9.79 Million
Q1 2022

Apr 27, 2022

SELL
$131.98 - $163.75 $373,239 - $463,085
-2,828 Reduced 4.16%
65,208 $10.6 Million
Q4 2021

Feb 02, 2022

BUY
$107.43 - $135.93 $364,080 - $460,666
3,389 Added 5.24%
68,036 $9.21 Million
Q3 2021

Oct 12, 2021

SELL
$106.4 - $120.78 $487,737 - $553,655
-4,584 Reduced 6.62%
64,647 $6.97 Million
Q2 2021

Aug 03, 2021

SELL
$105.21 - $117.21 $21,042 - $23,442
-200 Reduced 0.29%
69,231 $7.8 Million
Q1 2021

Apr 15, 2021

SELL
$102.3 - $112.62 $181,684 - $200,013
-1,776 Reduced 2.49%
69,431 $7.51 Million
Q4 2020

Feb 04, 2021

BUY
$80.49 - $108.67 $81,536 - $110,082
1,013 Added 1.44%
71,207 $7.63 Million
Q3 2020

Oct 19, 2020

BUY
$85.91 - $100.83 $494,669 - $580,579
5,758 Added 8.94%
70,194 $6.15 Million
Q2 2020

Jul 16, 2020

SELL
$73.37 - $98.18 $77,258 - $103,383
-1,053 Reduced 1.61%
64,436 $6.33 Million
Q1 2020

Apr 29, 2020

BUY
$64.5 - $97.79 $73,465 - $111,382
1,139 Added 1.77%
65,489 $4.99 Million
Q4 2019

Jan 21, 2020

BUY
$72.13 - $90.25 $96,582 - $120,844
1,339 Added 2.13%
64,350 $5.7 Million
Q3 2019

Oct 18, 2019

BUY
$62.98 - $75.72 $199,079 - $239,350
3,161 Added 5.28%
63,011 $4.77 Million
Q2 2019

Jul 10, 2019

BUY
$65.7 - $83.98 $2,562 - $3,275
39 Added 0.07%
59,850 $4.35 Million
Q1 2019

Apr 04, 2019

BUY
$77.14 - $90.79 $66,957 - $78,805
868 Added 1.47%
59,811 $4.82 Million
Q4 2018

Feb 13, 2019

BUY
$77.85 - $96.01 $21,642 - $26,690
278 Added 0.47%
58,943 $5.43 Million
Q3 2018

Oct 17, 2018

SELL
$88.91 - $98.84 $27,651 - $30,739
-311 Reduced 0.53%
58,665 $5.55 Million
Q2 2018

Jul 20, 2018

SELL
$89.78 - $106.23 $47,762 - $56,514
-532 Reduced 0.89%
58,976 $5.46 Million
Q1 2018

May 03, 2018

SELL
$92.01 - $123.21 $555,556 - $743,941
-6,038 Reduced 9.21%
59,508 $5.63 Million
Q4 2017

Feb 07, 2018

SELL
$89.56 - $98.21 $166,492 - $182,572
-1,859 Reduced 2.76%
65,546 $6.34 Million
Q3 2017

Oct 16, 2017

BUY
$69.85 - $89.22 $4.71 Million - $6.01 Million
67,405
67,405 $5.99 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $290B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Iowa State Bank Portfolio

Follow Iowa State Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iowa State Bank, based on Form 13F filings with the SEC.

News

Stay updated on Iowa State Bank with notifications on news.